人工智能在老年慢性阻塞性肺疾病合并肺癌诊疗中的应用价值

doi:10.3969/j.issn.1003-9198.2026.03.014

摘要/Abstract

摘要： 本文回顾总结了人工智能(artificial intelligence,AI)在老年COPD合并肺癌患者的筛查、早期诊断、辅助病理诊断与组织学分类、疾病严重程度的评估、预后评估的应用场景及实践价值。提示AI结合影像学、机器学习等技术可突破传统诊疗局限,显著提高诊断的准确性;但目前AI在临床应用中面临隐私、伦理、数据标准化等问题。在未来,需进一步优化数据库,完善相关标准体系,以推动AI在老年COPD合并肺癌诊疗中的规范应用。

关键词: 慢性阻塞性肺疾病, 肺癌, 合并症, 肺结节, 人工智能

Abstract: This article reviews and summarizes the application scenarios and practical value of artificial intelligence (AI) in the screening, early diagnosis, auxiliary pathological diagnosis and histological classification, assessment of disease severity, and prognosis evaluation of elderly patients with chronic obstructive pulmonary disease (COPD) complicated by lung cancer. It indicates that AI, by integrating imaging techniques, machine learning and other technologies, can break through the limitations of traditional diagnosis and treatment, and significantly enhance the diagnostic accuracy. However, in current clinical applications, AI is confronted with issues including privacy concerns, ethical issues, and data standardization. In the future, it is necessary to further optimize databases and improve relevant standard systems to standardize and promote the application of AI in the diagnosis and treatment of elderly patients with COPD complicated by lung cancer.

Key words: chronic obstructive pulmonary disease, lung cancer, comorbidity, pulmonary nodule, artificial intelligence

中图分类号:

王婷, 王菲, 温红侠. 人工智能在老年慢性阻塞性肺疾病合并肺癌诊疗中的应用价值[J]. 实用老年医学, 2026, 40(3): 294-298.

WANG Ting, WANG Fei, WEN Hongxia. Clinical utility of artificial intelligence in elderly patients with chronic obstructive pulmonary disease complicated by lung cancer[J]. Practical Geriatrics, 2026, 40(3): 294-298.

参考文献

[1] 陈典, 隆寰宇, 张丛溪, 等. 2025年GOLD慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2025, 28(16): 1937-1949.
[2] CHRISTENSON S A, SMITH B M, BAFADHEL M, et al. Chronic obstructive pulmonary disease[J]. Lancet, 2022, 399(10342):2227-2242.
[3] WANG C, XU J, YANG L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
[4] 李艳, 窦彤, 王肖潇, 等. 胸部CT对老年重度慢性阻塞性肺疾病病人的评估价值[J]. 实用老年医学, 2025, 39(1): 46-50.
[5] MACHIDA H, INOUE S, SHIBATA Y, et al. The incidence and risk analysis of lung cancer development in patients with chronic obstructive pulmonary disease: possible effectiveness of annual CT-screening[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16: 739-749.
[6] LIN X, ZHANG Z, ZHOU T, et al. The role of computed tomography and artificial intelligence in evaluating the comorbidities of chronic obstructive pulmonary disease: a one-stop CT scanning for lung cancer screening[J]. Int J Chron Obstruct Pulmon Dis, 2025, 20: 1395-1406.
[7] LEE D, YOON S N. Application of artificial intelligence-based technologies in the healthcare industry: opportunities and challenges[J]. Int J Environ Res Public Health, 2021, 18(1): 271.
[8] WU Y, XIA S, LIANG Z, et al. Artificial intelligence in COPD CT images: identification, staging, and quantitation[J]. Respir Res, 2024, 25(1): 319.
[9] 吴漫, 吴健卫, 徐非洲, 等. 慢性阻塞性肺疾病合并肺癌现状调查及预后初探[J]. 临床肺科杂志, 2025, 30(2): 219-225.
[10] DE TORRES J P, MARÍN J M, CASANOVA C, et al. Lung cancer in patients with chronic obstructive pulmonary disease: incidence and predicting factors[J]. Am J Respir Crit Care Med, 2011, 184(8): 913-919.
[11] DAI J, YANG P, COX A, et al. Lung cancer and chronic obstructive pulmonary disease:from a clinical perspective[J]. Oncotarget, 2017, 8(11): 18513-18524.
[12] SHEN J, GAO C, LOU X, et al. The association between emphysema detected on computed tomography and increased risk of lung cancer: a systematic review and meta-analysis[J]. Quant Imaging Med Surg, 2025, 15(3): 2193-2208.
[13] 杨晨, 杨中卫, 李威. 探索慢性阻塞性肺疾病临床异质性、肺气肿亚型与肺癌的关系[J]. 中国医学工程, 2023, 31(11): 33-38.
[14] LIU W, WU Y, ZHENG Z, et al. Enhancing diagnostic accuracy of lung nodules in chest computed tomography using artificial intelligence: retrospective analysis[J]. J Med Internet Res, 2025, 27: e64649.
[15] WEI Y, ZHOU Q, WU J, et al. Review of artificial intelligence in lung nodule risk assessment[J]. IEEE Rev Biomed Eng, 2025. DOI: 10.1109/RBME.2025.3528946.
[16] DURANTI L, TAVECCHIO L, ROLLI L, et al. New perspectives on lung cancer screening and artificial intelligence[J]. Life: Basel, 2025, 15(3): 498.
[17] ZHANG L, YANG D, YE X, et al. Successful application of artificial intelligence-assisted analysis of invasive pulmonary adenocarcinoma less than 6 mm in size: a case report and literature review[J]. Clin Respir J, 2025, 19(5): e70073.
[18] ZHAO Y, DE BOCK G H, VLIEGENTHART R, et al. Performance of computer-aided detection of pulmonary nodules in low-dose CT: comparison with double reading by nodule volume[J]. Eur Radiol, 2012, 22(10): 2076-2084.
[19] HUANG D, LI Z, JIANG T, et al. Artificial intelligence in lung cancer: current applications, future perspectives, and challenges[J]. Front Oncol, 2024, 14: 1486310.
[20] WANG C, CHEN B, LIANG S, et al. China protocol for early screening, precise diagnosis, and individualized treatment of lung cancer[J]. Signal Transduct Target Ther, 2025, 10(1):175.
[21] GRENIER P A. COPD: artificial intelligence detects and quantifies anomalies on chest CT enabling prediction of disease severity[J]. Eur Radiol, 2024, 34(7): 4376-4378.
[22] BERMEJO-PELÁEZ D, SAN JOSÉ ESTÉPAR R, LEDESMA-CARBAYO M J. Emphysema classification using a multi-view convolutional network[J]. Proc IEEE Int Symp Biomed Imaging, 2018, 2018: 519-522.
[23] SHIN H J, KWAK S H, KIM K Y, et al. Effectiveness of artificial intelligence for detecting operable lung cancer on chest radiographs[J]. Transl Lung Cancer Res, 2024, 13(12): 3473-3485.
[24] LOCOCO F, GHALY G, FLAMINI S, et al. Artificial intelligence applications in personalizing lung cancer management: state of the art and future perspectives[J]. J Thorac Dis, 2024, 16(10): 7096-7110.
[25] WU Q, HUANG Y, WANG S, et al. Artificial intelligence in lung cancer screening: detection, classification, prediction, and prognosis[J]. Cancer Med, 2024, 13(7): e7140.
[26] KAHNERT K, JÖRRES R A, BEHR J, et al. The diagnosis and treatment of COPD and its comorbidities[J]. Dtsch Arztebl Int, 2023, 120(25): 434-444.
[27] JIANG L, ZHOU Y, MIAO W, et al. Artificial intelligence-assisted quantitative CT parameters in predicting the degree of risk of solitary pulmonary nodules[J]. Ann Med, 2024, 56(1): 2405075.
[28] LI Y, DENG J, MA X, et al. Diagnostic accuracy of CT and PET/CT radiomics inpredicting lymph node metastasis in non-small cell lung cancer[J]. Eur Radiol, 2025, 35(4): 1966-1979.
[29] 郑莉莉, 陈恒屹. 慢性阻塞性肺疾病合并肺癌的发病机制与治疗研究进展[J]. 检验医学与临床, 2024, 21(19): 2935-2940.
[30] SHEN J, WANG S, GUAN H, et al. Artificial intelligence in automatic image segmentation system for exploring recurrence patterns in small cell carcinoma of the lung[J]. Front Oncol, 2025, 15: 1534740.
[31] CLAUDIO QUIROS A, COUDRAY N, YEATON A, et al. Mapping the landscape of histomorphological cancer phenotypes using self-supervised learning on unannotated pathology slides[J]. Nat Commun, 2024, 15(1): 4596.
[32] AYASA Y, ALAJRAMI D, IDKEDEK M, et al. The impact of artificial intelligence on lung cancer diagnosis and personalized treatment[J]. Int J Mol Sci, 2025, 26(17): 8472.